← Back to feed

GENinCode

GENI · AIM · Health Care · mcap £4.9m today

All announcements

All RNS · 32 Key events · 14

30 Sep 26

Holding(s) in Company
RNS 9799799 ↗
29 Sep 26

Half-year Results Net cash ≈ market cap

GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease (“CVD”) and risk of ovarian cancer announces its unaudited interim results for the six months ended 30 June 2026.
RNS 9795227 ↗
22 Sep 26

Notice of Results
RNS 9783263 ↗
28 Aug 26

CARDIO inCode-Score milestone clinical results

CARDIO inCode-Score® milestone clinical results for prevention of coronary artery disease
RNS 9744363 ↗
01 Jul 26

Result of AGM
RNS 9647739 ↗
11 Jun 26

Holding(s) in Company
RNS 9614590 ↗
10 Jun 26

Holding(s) in Company
RNS 9612128 ↗
08 Jun 26

Final Results Voting rights down

Well positioned for accelerated commercial scale up with revenue growth and expanding US adoption
RNS 9605294 ↗
04 Jun 26

Holding(s) in Company
RNS 9602964 ↗
03 Jun 26

Holding(s) in Company
RNS 9599902 ↗
22 May 26

Notice of Results
RNS 9581341 ↗
08 May 26

Holding(s) in Company
RNS 9560117 ↗
07 May 26

Grant of Share Options & PDMR Dealings

Grant of Share Options, Surrender of Existing Options & PDMR Dealings
RNS 9555980 ↗
15 Apr 26

Holding(s) in Company
RNS 9521891 ↗
14 Apr 26

Holding(s) in Company
RNS 9519818 ↗
26 Feb 26

Holding(s) in Company
RNS 9449423 ↗
24 Feb 26

Holding(s) in Company
RNS 9444932 ↗
12 Feb 26

Holding(s) in Company
RNS 9428758 ↗
12 Feb 26

Holding(s) in Company
RNS 9428739 ↗
12 Feb 26

Holding(s) in Company
RNS 9428738 ↗
09 Feb 26

Result of GM, Director Shareholdings and TVR Director buys

Result of General Meeting, Director Shareholdings and Total Voting Rights
RNS 9421841 ↗
06 Feb 26

Additional Subscription

GENinCode (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease and ovarian cancer, is pleased to announce that further to the Fundraising initially announced on 21 January 2026, it has received addition interest...
RNS 9415721 ↗
26 Jan 26

Result of Retail Offer

GENinCode (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease and ovarian cancer, is pleased to announce that the WRAP Retail Offer launched on 21 January 2026 has now closed, raising aggregate gross proceeds of...
RNS 9387533 ↗
22 Jan 26

Result of Placing and Subscription

Further to the announcement made yesterday regarding a proposed placing, subscription and retail offer (the "Launch Announcement"), GENinCode plc (AIM: GENI) is pleased to announce that, it has conditionally raised gross proceeds of £3.9 million (before...
RNS 9375636 ↗
21 Jan 26

Retail Offer

GENinCode Plc (AIM: GENI), the genetics company focused on the prevention of cardiovascular disease ("CVD") and the early detection of ovarian cancer, is pleased to announce a retail offer via the Winterflood Retail Access Platform ("WRAP") to raise up to...
RNS 9373507 ↗
21 Jan 26

Placing and Subscription

THIS ANNOUNCEMENT SHOULD BE READ IN ITS ENTIRETY.
RNS 9373501 ↗
17 Dec 25

Collaboration with Sohin Genetics

for the genetic risk prediction and prevention of coronary heart disease
RNS 9302495 ↗
08 Dec 25

Holding(s) in Company
RNS 9282871 ↗
04 Dec 25

Collaboration with Thermo Fisher

Commercialisation agreement to sell, distribute and manufacture CARDIO inCode-Score®
RNS 9274793 ↗
03 Dec 25

Approval of CARDIO inCode-score in New York state

New York State clinical test approval of CARDIO inCode-score®
RNS 9271982 ↗
27 Oct 25

Publication of Landmark Study in JACC: Advances

Validation of CARDIO inCode-Score® for improved coronary heart disease risk prediction
RNS 9195053 ↗
13 Oct 25

Holding(s) in Company
RNS 9168073 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.